{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:05:56Z","timestamp":1746763556376,"version":"3.40.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Ficolin-3 is a crucial protein for the activation of the complement system. Previous work has indicated this protein may play a role in the pathogenesis of rheumatic heart disease (RHD), and it has been hypothesised that ficolin-3 has potential as a biomarker for early identification of patients with suspected RHD. This study investigated <jats:italic>FCN3<\/jats:italic> gene polymorphisms rs532781899 (c.349del) and rs4494157 (c.658\u2009+\u2009250\u00a0C\u2009&gt;\u2009A) and ficolin-3 serum concentrations in an ethnically diverse cohort of 53 RHD cases and 45 healthy controls from across Africa.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Ficolin-3 was found to be increased by 16% in RHD patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) compared to controls, but polymorphisms did not associate with the risk of developing RHD nor with ficolin-3 concentrations. Carriers of the c.349del haploinsufficiency locus had normal levels of ficolin-3, while the previously described c.658\u2009+\u2009250\u00a0C\u2009&gt;\u2009A RHD susceptibility locus was found equally in cases and controls. The higher serum ficolin-3 in RHD supports the potential role of this protein in RHD pathogenesis. However, these results suggest that rs532781899 and rs4494157 are not risk factors for the development of RHD in patients from sub-Saharan Africa and would not be reliable as early-stage markers of RHD susceptibility.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13104-025-07251-x","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T07:26:19Z","timestamp":1746689179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Ficolin-3 deficiency as a risk factor in the development of rheumatic heart disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Zahra","family":"Parker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Taariq","family":"Salie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e9lin","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesl J","family":"Z\u00fchlke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy F","family":"Spracklen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"7251_CR1","doi-asserted-by":"publisher","first-page":"612716","DOI":"10.3389\/fcvm.2020.612716","volume":"7","author":"LSA Passos","year":"2020","unstructured":"Passos LSA, Nunes MCP, Aikawa E. Rheumatic heart valve disease pathophysiology and underlying mechanisms. Front Cardiovasc Med. 2020;7:612716. https:\/\/doi.org\/10.3389\/fcvm.2020.612716.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"7251_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0974-2069.79617","volume":"4","author":"L Guilherme","year":"2011","unstructured":"Guilherme L, K\u00f6hler KF, Postol E, Kalil J. Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol. 2011;4(1):13\u201321. https:\/\/doi.org\/10.4103\/0974-2069.79617.","journal-title":"Ann Pediatr Cardiol"},{"issue":"8","key":"7251_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","volume":"377","author":"DA Watkins","year":"2017","unstructured":"Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT, Mayosi BM, Mensah GA, Nascimento BR, Ribeiro ALP, Sable CA, Steer AC, Naghavi M, Mokdad AH, Murray CJL, Vos T, Carapetis JR, Roth GA. Global, regional, and National burden of rheumatic heart disease, 1990\u20132015. N Engl J Med. 2017;377(8):713\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603693.","journal-title":"N Engl J Med"},{"issue":"1","key":"7251_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ajum.12203","volume":"23","author":"G Whalley","year":"2020","unstructured":"Whalley G. Appropriate and early detection of rheumatic heart disease. Australas J Ultrasound Med. 2020;23(1):3\u20134. https:\/\/doi.org\/10.1002\/ajum.12203.","journal-title":"Australas J Ultrasound Med"},{"issue":"1","key":"7251_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/0974-2069.197051","volume":"10","author":"S Dougherty","year":"2017","unstructured":"Dougherty S, Khorsandi M, Herbst P. Rheumatic heart disease screening: current concepts and challenges. Ann Pediatr Cardiol. 2017;10(1):39\u201349. https:\/\/doi.org\/10.4103\/0974-2069.197051.","journal-title":"Ann Pediatr Cardiol"},{"issue":"1","key":"7251_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12014-022-09345-1","volume":"19","author":"MT Salie","year":"2022","unstructured":"Salie MT, Yang J, Ram\u00edrez Medina CR, Z\u00fchlke LJ, Chishala C, Ntsekhe M, Gitura B, Ogendo S, Okello E, Lwabi P, Musuku J, Mtaja A, Hugo-Hamman C, El-Sayed A, Damasceno A, Mocumbi A, Bode-Thomas F, Yilgwan C, Amusa GA, Nkereuwem E, Shaboodien G, Da Silva R, Lee DCH, Frain S, Geifman N, Whetton AD, Keavney B, Engel ME. Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases. Clin Proteom. 2022;19(1):7. https:\/\/doi.org\/10.1186\/s12014-022-09345-1.","journal-title":"Clin Proteom"},{"issue":"1","key":"7251_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13104-021-05450-w","volume":"14","author":"MH Gomaa","year":"2021","unstructured":"Gomaa MH, Khidr EG, Elshafei A, Hamza HS, Fattouh AM, El-Husseiny AA, Aglan A, Eldeib MG. The clinical value of ficolin-3 gene polymorphism in rheumatic heart disease. An Egyptian adolescents study. BMC Res Notes. 2021;14(1):36. https:\/\/doi.org\/10.1186\/s13104-021-05450-w.","journal-title":"BMC Res Notes"},{"key":"7251_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2020.11.006","volume":"229","author":"SJ Catarino","year":"2021","unstructured":"Catarino SJ, Andrade FA, Bavia L, Guilherme L, Messias-Reason IJ. Ficolin-3 in rheumatic fever and rheumatic heart disease. Immunol Lett. 2021;229:27\u201331. https:\/\/doi.org\/10.1016\/j.imlet.2020.11.006.","journal-title":"Immunol Lett"},{"issue":"7","key":"7251_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/1744666x.2020.1792779","volume":"16","author":"F Babaha","year":"2020","unstructured":"Babaha F, Abolhassani H, Hamidi Esfahani Z, Yazdani R, Aghamohammadi A. A new case of congenital ficolin-3 deficiency with primary immunodeficiency. Expert Rev Clin Immunol. 2020;16(7):733\u20138. https:\/\/doi.org\/10.1080\/1744666x.2020.1792779.","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"7251_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.imbio.2015.01.003","volume":"220","author":"M Michalski","year":"2015","unstructured":"Michalski M, \u015awierzko AS, P\u0105gowska-Klimek I, Niemir ZI, Mazerant K, Dom\u017calska-Popadiuk I, Moll M, Cedzy\u0144ski M. Primary Ficolin-3 deficiency\u2013Is it associated with increased susceptibility to infections? Immunobiology. 2015;220(6):711\u20133. https:\/\/doi.org\/10.1016\/j.imbio.2015.01.003.","journal-title":"Immunobiology"},{"issue":"25","key":"7251_CR11","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1056\/NEJMoa0900381","volume":"360","author":"L Munthe-Fog","year":"2009","unstructured":"Munthe-Fog L, Hummelsh\u00f8j T, Honor\u00e9 C, Madsen HO, Permin H, Garred P. Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med. 2009;360(25):2637\u201344. https:\/\/doi.org\/10.1056\/NEJMoa0900381.","journal-title":"N Engl J Med"},{"issue":"9","key":"7251_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamacardio.2021.1627","volume":"6","author":"T Machipisa","year":"2021","unstructured":"Machipisa T, Chong M, Muhamed B, Chishala C, Shaboodien G, Pandie S, de Vries J, Laing N, Joachim A, Daniels R, Ntsekhe M, Hugo-Hamman CT, Gitura B, Ogendo S, Lwabi P, Okello E, Damasceno A, Novela C, Mocumbi AO, Madeira G, Musuku J, Mtaja A, ElSayed A, Elhassan HHM, Bode-Thomas F, Okeahialam BN, Z\u00fchlke LJ, Mulder N, Ramesar R, Lesosky M, Parks T, Cordell HJ, Keavney B, Engel ME, Par\u00e9 G. Association of novel locus with rheumatic heart disease in black African individuals: findings from the RHDGen study. JAMA Cardiol. 2021;6(9):1000\u201311. https:\/\/doi.org\/10.1001\/jamacardio.2021.1627.","journal-title":"JAMA Cardiol"},{"issue":"9","key":"7251_CR13","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.molimm.2007.12.012","volume":"45","author":"L Munthe-Fog","year":"2008","unstructured":"Munthe-Fog L, Hummelsh\u00f8j T, Ma YJ, Hansen BE, Koch C, Madsen HO, Skj\u00f8dt K, Garred P. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol. 2008;45(9):2660\u20136. https:\/\/doi.org\/10.1016\/j.molimm.2007.12.012.","journal-title":"Mol Immunol"},{"issue":"2","key":"7251_CR14","doi-asserted-by":"publisher","first-page":"e0005409","DOI":"10.1371\/journal.pntd.0005409","volume":"11","author":"FA Andrade","year":"2017","unstructured":"Andrade FA, Beltrame MH, Bini VB, Gon\u00e7alves LB, Boldt AB, de Messias-Reason IJ. Association of a new FCN3 haplotype with high ficolin-3 levels in leprosy. PLoS Negl Trop Dis. 2017;11(2):e0005409. https:\/\/doi.org\/10.1371\/journal.pntd.0005409.","journal-title":"PLoS Negl Trop Dis"},{"key":"7251_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev.immunol.21.120601.140954","volume":"21","author":"U Holmskov","year":"2003","unstructured":"Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol. 2003;21:547\u201378. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.140954.","journal-title":"Annu Rev Immunol"},{"key":"7251_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fped.2014.00148","volume":"2","author":"MH Beltrame","year":"2014","unstructured":"Beltrame MH, Catarino SJ, Goeldner I, Boldt AB, de Messias-Reason IJ. The lectin pathway of complement and rheumatic heart disease. Front Pediatr. 2014;2:148. https:\/\/doi.org\/10.3389\/fped.2014.00148.","journal-title":"Front Pediatr"},{"issue":"1","key":"7251_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger JR, Song WC. Complement and its role in innate and adaptive immune responses. Cell Res. 2010;20(1):34\u201350. https:\/\/doi.org\/10.1038\/cr.2009.139.","journal-title":"Cell Res"},{"issue":"16","key":"7251_CR18","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1016\/j.molimm.2007.06.005","volume":"44","author":"S Thiel","year":"2007","unstructured":"Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, Ficolins and associated proteins. Mol Immunol. 2007;44(16):3875\u201388. https:\/\/doi.org\/10.1016\/j.molimm.2007.06.005.","journal-title":"Mol Immunol"},{"issue":"6","key":"7251_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00281-021-00892-7","volume":"43","author":"RB Pouw","year":"2021","unstructured":"Pouw RB, Ricklin D. Tipping the balance: intricate roles of the complement system in disease and therapy. Semin Immunopathol. 2021;43(6):757\u201371. https:\/\/doi.org\/10.1007\/s00281-021-00892-7.","journal-title":"Semin Immunopathol"},{"issue":"7","key":"7251_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1080\/08916934.2020.1809654","volume":"53","author":"C Pieczarka","year":"2020","unstructured":"Pieczarka C, Andrade FA, Catarino SJ, Lidani KCF, Bavia L, Tizzot R, Skare T, de Messias-Reason IJ. Ficolin-1 and ficolin-3 polymorphisms and susceptibility to rheumatoid arthritis. Autoimmunity. 2020;53(7):400\u20137. https:\/\/doi.org\/10.1080\/08916934.2020.1809654.","journal-title":"Autoimmunity"},{"issue":"4","key":"7251_CR21","doi-asserted-by":"publisher","first-page":"e23732","DOI":"10.1002\/jcla.23732","volume":"35","author":"Y Li","year":"2021","unstructured":"Li Y, You EQ, Lin WH, Liu XN, Shen DP, Zhang XL, Ma DC, Li HM. Association of ficolin-1 and ficolin-3 gene variation and pulmonary tuberculosis susceptibility in a Chinese population. J Clin Lab Anal. 2021;35(4):e23732. https:\/\/doi.org\/10.1002\/jcla.23732.","journal-title":"J Clin Lab Anal"},{"issue":"5","key":"7251_CR22","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/10641963.2012.665538","volume":"34","author":"J Lu","year":"2012","unstructured":"Lu J, Li M, Zhang R, Hu C, Wang C, Jiang F, Yu W, Qin W, Tang S, Jia W. A common genetic variant of FCN3\/CD164L2 is associated with essential hypertension in a Chinese population. Clin Exp Hypertens. 2012;34(5):377\u201382. https:\/\/doi.org\/10.3109\/10641963.2012.665538.","journal-title":"Clin Exp Hypertens"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07251-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07251-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T19:02:59Z","timestamp":1746730979000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07251-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7251"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07251-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the University of Cape Town Human Research Ethics Committee (reference 310\/2013). All participants over the age of 18 years provided written informed consent during recruitment; for participants under 18 years, consent was obtained from a parent or legal guardian. This study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}